Alfresa Holdings Corporation (2784) Stock Price & News

2784:TYO

Alfresa Holdings Corporation

¥2,238.00

+0.54%

(+12.00) 1D

Oct 9, 9:19:01 AM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 2784...

Open

¥2,259

High

¥2,260

Low

¥2,236

Mkt. cap

424.69B

Avg. vol.

434.47K

Volume

52.60K

Dividend

3.04%

Quarterly dividend

¥17

Ex-dividend date

Sep 29, 2026

P/E ratio

10.36

52-wk high

¥2,686

52-wk low

¥2,070

EPS

¥216

Shares outstanding

211.68M

No. of employees

13K

Open

¥2,259

High

¥2,260

Low

¥2,236

Mkt. cap

424.69B

Avg. vol.

434.47K

Volume

52.60K

Dividend

3.04%

Quarterly dividend

¥17

Ex-dividend date

Sep 29, 2026

P/E ratio

10.36

52-wk high

¥2,686

52-wk low

¥2,070

EPS

¥216

Shares outstanding

211.68M

No. of employees

13K

Related stocks

4502

Takeda Pharmaceutical Co Ltd

Sumitomo Pharma Co Ltd

News stories

From web sources and news partners

CNBC

1 hour ago

Jim Cramer talks what lead the Dow higher while the Nasdaq sunk

TipRanks

17 minutes ago

Closing Bell Movers: Telecom stocks fall on SpaceX spectrum license

MarketWatch

3 hours ago

S&P Global Inc. stock underperforms Thursday when compared to competitors despite daily gains

TradingView

3 hours ago

Analyst Sets Stark S&P 500 Target For 2027

About Alfresa Holdings Corporation

CEO-

Employees12.5K

FoundedSep 29, 2003

Headquarters-

SectorHealth care provider

Websitealfresa.com

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	771.64B	833.32B	740.98B	788.96B
Cost of goods sold	717.73B	773.94B	688.23B	736.20B
Cost of revenue	717.73B	773.94B	688.23B	736.20B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	44.67B	45.90B	34.59B	47.17B
Operating expense	44.67B	45.90B	46.31B	47.17B
Total operating expenses	762.40B	819.85B	734.54B	783.36B
Operating income	9.24B	13.47B	6.44B	5.60B
Other non operating income	8.00M	295.00M	105.00M	132.00M
EBT including unusual items	10.24B	29.44B	14.70B	5.10B
EBT excluding unusual items	9.83B	14.16B	6.99B	6.09B
Income tax expense	3.66B	8.96B	4.96B	2.48B
Effective tax rate	35.71%	30.45%	33.76%	48.61%
Other operating expenses	-	-	-	-
Net income	6.52B	20.46B	9.76B	2.48B
Net profit margin	0.84%	2.46%	1.32%	0.31%
Earnings per share	-	-	-	-
Interest and investment income	670.00M	474.00M	541.00M	458.00M
Interest expense	-89.00M	-86.00M	-94.00M	-99.00M
Net interest expenses	581.00M	388.00M	447.00M	359.00M
Depreciation and amortization charges	-	-	11.38B	-
EBITDA	12.84B	-	10.20B	9.36B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything